Align Technology | ALGN - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
3M USD 214M 18M 2026-03
Align Technology USD 16.04M 14.04M 2025-12
Becton, Dickinson and Co. USD 149M 4M 2026-03
Bruker USD 8.1M 11.9M 2025-12
Cardinal Health USD 101M 13M 2026-03
Charles River Laboratories USD 26.74M 2.97M 2026-03
Cooper Companies USD 22.4M 2M 2025-12
CVS Health USD 774M 13M 2026-03
Danaher USD 63M 8M 2026-03
Dentsply International USD 24M 2M 2026-03
Dexcom USD 4.2M 500K 2025-12
Henry Schein USD 39M 0 2026-03
Idexx Laboratories USD 7.74M 2.34M 2026-03
Insulet USD 14.7M 5.5M 2026-03
Integra LifeSciences USD 22.46M 1.21M 2026-03
IQVIA Holdings USD 192M 1000K 2026-03
Masimo USD 6.1M 1.4M 2026-03
McKesson USD 63M 11M 2025-12
Mettler Toledo International USD 17.39M 307K 2025-12
Revvity USD 24.72M 1.2M 2026-03
Solventum Corp USD 14.1B 14.05B 2026-03
Stryker USD 46.29B 45.68B 2026-03
Teleflex USD 25.72M 2.43M 2026-03
Thermo Fisher Scientific USD 354M 11M 2026-03
Veeva Systems USD 65.1M 8.4M 2025-03
Waters USD 42M 33.38M 2026-03
Zimmer Biomet Holdings USD 68.8M 3.1M 2026-03
Zoetis USD 62M 5M 2026-03